Rundoo Co., Ltd. Brand Ranking
Industry: Ibuprofen , Raw materials
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Rundoo Co., Ltd.

Rundoo Co., Ltd.

Zhuhai Runduo Pharmaceutical Co., Ltd.
Industry: Ibuprofen , Raw materials
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Brand Introduction

Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern technology-based pharmaceutical enterprise integrating drug research and development, production and sales. It is located in Jinwan District, Zhuhai City, Guangdong Province and was established in 1999. On January 5, 2018, the company was listed on the Shenzhen Stock Exchange (Securities abbreviation: Rundu Co., Ltd.; Stock code: 002923). The company currently has more than 1,300 formal employees (including wholly-owned subsidiaries).

The company's main business is the research, development, production and sales of chemical preparations, chemical raw materials, and pharmaceutical intermediates. The product application scope covers peptic ulcers, hypertension, surgical anesthesia, antipyretic analgesia, anti-infection, diabetes and other products. field. The company has a complete quality management system and has established a drug production and manufacturing center strictly in accordance with the requirements of the national GMP. The existing product production lines (covering raw materials, tablets, capsules, preparation intermediates (micropellets), etc.) have passed the new national GMP version. Certification, some specialty raw material products have passed the official certification of the World Health Organization, the European Union, Japan, etc., and some products have passed the on-site inspection of the US FDA.

While the company continues to maintain outstanding development of unique new dosage forms of drugs (micro-pill capsule preparation technology, micro-pill tableting preparation technology, etc.), enteric-coated and slow-release preparation technology, it actively develops the development of original innovative drugs and multiple varieties of drugs. Technology upgrade; gradually promote the vertical integration of raw materials to preparations; carry out diversified R&D models, strengthen cooperation with R&D institutions with complete domestic and foreign technology, develop a series of preparation products, promote the company's international trade, and gradually realize The company's internationalization strategy strives to build a domestic enterprise that produces special products such as micropill preparations, anti-hypertensive sartan drugs, anti-peptic ulcer proton pump inhibitors and other special products.

Recommend Related Products

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号